HCAR2 and cancer: Reexpression of HCA2 in cancer cell lines induces apoptosis by inhibiting B-cell lymphoma (Bcl)-2, B-cell lymphoma-extra-large (Bcl-xL), cyclin D1 and NF-κB activity and upregulating the death receptor pathway in a ligand-dependent manner (Figure 3B).